Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
10.82
-0.14 (-1.28%)
Sep 30, 2025, 5:31 PM CET

Newron Pharmaceuticals Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
25.3315.84-16.22-17.49-14.9-21
Upgrade
Depreciation & Amortization
0.180.190.20.20.210.22
Upgrade
Stock-Based Compensation
0.240.260.20.480.761.46
Upgrade
Other Operating Activities
4.543.854.173.832.750.01
Upgrade
Change in Accounts Receivable
-9.39-44.22-1.31-0.881.751.23
Upgrade
Change in Accounts Payable
-0.682.630.580.58-3.950.56
Upgrade
Change in Other Net Operating Assets
4.343.842.242.191.931.94
Upgrade
Operating Cash Flow
24.57-17.61-10.14-11.09-11.45-15.59
Upgrade
Capital Expenditures
-0.04-0.01-0.01-0.02-0.02-0.03
Upgrade
Sale (Purchase) of Intangibles
-0-----0
Upgrade
Investment in Securities
-12.373.173.26-0.38.44-0.58
Upgrade
Investing Cash Flow
-12.43.163.25-0.328.42-0.62
Upgrade
Long-Term Debt Issued
----157.5
Upgrade
Long-Term Debt Repaid
--0.19-0.19-0.19-0.17-0.14
Upgrade
Net Debt Issued (Repaid)
-0.19-0.19-0.19-0.1914.837.37
Upgrade
Issuance of Common Stock
6.7715.41----
Upgrade
Other Financing Activities
--0.17----
Upgrade
Financing Cash Flow
6.5815.05-0.19-0.1914.837.37
Upgrade
Net Cash Flow
18.740.6-7.09-11.611.81-8.84
Upgrade
Free Cash Flow
24.53-17.63-10.15-11.11-11.47-15.62
Upgrade
Free Cash Flow Margin
40.97%-34.30%-112.08%-182.31%-198.98%-297.11%
Upgrade
Free Cash Flow Per Share
1.15-0.86-0.57-0.62-0.64-0.88
Upgrade
Cash Interest Paid
1.041.91.21.230.870.61
Upgrade
Levered Free Cash Flow
11.25-26.67-9.22-9.64-10.04-10.14
Upgrade
Unlevered Free Cash Flow
14-23.95-6.61-7.17-8.22-8.74
Upgrade
Change in Working Capital
-5.73-37.751.511.89-0.263.72
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.